Article
Case report: severe toxicity in an African-American patient receiving FOLFOX carrying uncommon allelic variants in DPYD.
Pharmacogenomics - 1 Jan 2021
Sissung Tristan M, Cordes Lisa, Peer Cody J, Gandhy Shruti, Redman Jason, Strauss Julius, Figg William D
Abstract excerpt
Cancers of the colon are commonly treated with fluoropyrimidines, which often cause severe toxicities in patients with certain variants in DPYD. Y186C (rs115232898) and a variant in the 3' untranslated region (rs12132152) are uncommon alleles previously observed in African-Americans. An African-American female underwent 5-fluorouracil-based therapy (400 mg/m2 bolus, 1200 mg/m2/day over 46 h). The patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
